NCT06205628

Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension

← Hub

Registry fields

Overall status: ACTIVE_NOT_RECRUITING
Conditions: Hypertension, Hypertension,Essential
Study type: INTERVENTIONAL
Phase: PHASE1
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: ADX-850, Placebo
Lead sponsor: ADARx Pharmaceuticals, Inc. (INDUSTRY)

Cached at: 2026-07-28 02:39:09

View on ClinicalTrials.gov

Brief summary

This Phase 1 study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ADX-850 in participants with hypertension.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report